Navigating Potential Side Effects With Confidence Whenever you start a new medication, it's normal to wonder what to expect
In cross-sectional studies, symptom severity, exercise limitations and hemodynamic abnormalities in the obesity phenotype of HFpEF worsen as BMI increases 6,7,8 , suggesting the possibility that beneficial effects from semaglutide could be mostly confined to individuals with HFpEF and very high BMI
[DOI] [PubMed] [Google Scholar] 79.Armstrong M.J., Gaunt P., Aithal G.P., Barton D., Hull D., Parker R., Hazlehurst J.M., Guo K., LEAN Trial Team
"Fewer than one in 10 patients who could benefit from GLP-1 treatments are actually taking them," said David Ricks, CEO of Eli Lilly
At Meeting Point Health, your provider will help choose the most appropriate administrative route that works for you